Leishmaniasis Supply Barriers in Africa - country perspective

Help us improve access to life-savings medicine for a neglected disease

This survey aims to explore barriers to effective supply of drugs to treat leishmaniasis, a killing disease. If you live or work in eastern Africa region, particularly in Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda.

PLEASE TAKE 4 MINUTES OF YOUR TIME TO ANSWER THIS SURVEY.

Thank you

Question Title

* 1. Which of the anti-leishmanial commodities below that is available in your country

Sodium stibogluconate

Paromomycin

Liposomal amphotericin B (AmBisome®)

Meglumine antimoniate (Glucantime®)

Pentostam®

Miltefosine

rK39 RDT Brand__________________

Question Title

* 2. Do you know if there is a leishmaniasis -or kala-azar- control programme in your country?

Yes

Don't know

Question Title

* 3. As a neglected disease, who do you think procure the leishmaniasis drug and diagnostics? (multiple responses possible)

Ministry of Health

Central Medical Store

WHO

International Non-Governmental Organizations (NGO)

Local NGOs

Other (please specify)

Question Title

* 4. Can you find leishmaniasis drugs outside public hospitals in your country?

Yes

Don’t know

Question Title

* 5. Can you purchase rapid test for leishmaniasis in the private pharmacies/lab in your country?

Yes

Don’t know

Question Title

* 6. Have you ever heard or experienced shortages of any of the anti leishmanial drug?

Yes

Don’t know

Question Title

* 7. If yes, which one?

SSG

Paromomycin

Liposomal amphotericin B (AmBisome®)

Meglumine antimoniate (Glucantime®)

Pentostam®

Miltefosine

rK39 RDT Brand__________________

Other (please specify)

Question Title

* 8. On a scale from 1 (not at all important) to 5 (extremely important), please rate how each issue acts as supply barrier to leishmanial drugs and diagnostics, according to you. By importance, we mean how critical the issue is in access to anti-leishmanial commodities. The more you feel the issue is important.

	1-Not at all important	2	3	4	5-Extremely important	N/A
Lack of forecasting	Lack of forecasting 1-Not at all important	Lack of forecasting 2	Lack of forecasting 3	Lack of forecasting 4	Lack of forecasting 5-Extremely important	Lack of forecasting N/A
Importation issue	Importation issue 1-Not at all important	Importation issue 2	Importation issue 3	Importation issue 4	Importation issue 5-Extremely important	Importation issue N/A
No control programme taking responsibility	No control programme taking responsibility 1-Not at all important	No control programme taking responsibility 2	No control programme taking responsibility 3	No control programme taking responsibility 4	No control programme taking responsibility 5-Extremely important	No control programme taking responsibility N/A
The product is not registered in the country	The product is not registered in the country 1-Not at all important	The product is not registered in the country 2	The product is not registered in the country 3	The product is not registered in the country 4	The product is not registered in the country 5-Extremely important	The product is not registered in the country N/A
Lack of production (single manufacturer)	Lack of production (single manufacturer) 1-Not at all important	Lack of production (single manufacturer) 2	Lack of production (single manufacturer) 3	Lack of production (single manufacturer) 4	Lack of production (single manufacturer) 5-Extremely important	Lack of production (single manufacturer) N/A
Quality of the product	Quality of the product 1-Not at all important	Quality of the product 2	Quality of the product 3	Quality of the product 4	Quality of the product 5-Extremely important	Quality of the product N/A
Expensive cost of the product (price is too high)	Expensive cost of the product (price is too high) 1-Not at all important	Expensive cost of the product (price is too high) 2	Expensive cost of the product (price is too high) 3	Expensive cost of the product (price is too high) 4	Expensive cost of the product (price is too high) 5-Extremely important	Expensive cost of the product (price is too high) N/A
Limited number of suppliers	Limited number of suppliers 1-Not at all important	Limited number of suppliers 2	Limited number of suppliers 3	Limited number of suppliers 4	Limited number of suppliers 5-Extremely important	Limited number of suppliers N/A
The drug is not included in the national medicine list	The drug is not included in the national medicine list 1-Not at all important	The drug is not included in the national medicine list 2	The drug is not included in the national medicine list 3	The drug is not included in the national medicine list 4	The drug is not included in the national medicine list 5-Extremely important	The drug is not included in the national medicine list N/A
Transport difficulties/ delivery to health facility	Transport difficulties/ delivery to health facility 1-Not at all important	Transport difficulties/ delivery to health facility 2	Transport difficulties/ delivery to health facility 3	Transport difficulties/ delivery to health facility 4	Transport difficulties/ delivery to health facility 5-Extremely important	Transport difficulties/ delivery to health facility N/A
Procurement is not done through government	Procurement is not done through government 1-Not at all important	Procurement is not done through government 2	Procurement is not done through government 3	Procurement is not done through government 4	Procurement is not done through government 5-Extremely important	Procurement is not done through government N/A
Complicated procurement mechanisms	Complicated procurement mechanisms 1-Not at all important	Complicated procurement mechanisms 2	Complicated procurement mechanisms 3	Complicated procurement mechanisms 4	Complicated procurement mechanisms 5-Extremely important	Complicated procurement mechanisms N/A

Other (please specify)

Question Title

* 9. Do you think the procurement of diagnostic and drugs for leishmaniasis should be integrated with the procurement for other essential medicines?

Yes

Not sure

Question Title

* 10. On a scale from 1 (not at all relevant) to 5 (extremely relevant), please rate how important you think is that action. By importance, we mean how likely that action is to succeed to overcome the barriers.

	1-Not at all relevant	2	3	4	5 Extremely relevant
Reduce the price	Reduce the price 1-Not at all relevant	Reduce the price 2	Reduce the price 3	Reduce the price 4	Reduce the price 5 Extremely relevant	Reduce the price
Improve distribution practices	Improve distribution practices 1-Not at all relevant	Improve distribution practices 2	Improve distribution practices 3	Improve distribution practices 4	Improve distribution practices 5 Extremely relevant	Improve distribution practices
National control programme ownership of procurement	National control programme ownership of procurement 1-Not at all relevant	National control programme ownership of procurement 2	National control programme ownership of procurement 3	National control programme ownership of procurement 4	National control programme ownership of procurement 5 Extremely relevant	National control programme ownership of procurement
Training of the staff on better supply management	Training of the staff on better supply management 1-Not at all relevant	Training of the staff on better supply management 2	Training of the staff on better supply management 3	Training of the staff on better supply management 4	Training of the staff on better supply management 5 Extremely relevant	Training of the staff on better supply management
Pooled procurement between countries	Pooled procurement between countries 1-Not at all relevant	Pooled procurement between countries 2	Pooled procurement between countries 3	Pooled procurement between countries 4	Pooled procurement between countries 5 Extremely relevant	Pooled procurement between countries
Encourage more producers of the product, including generics	Encourage more producers of the product, including generics 1-Not at all relevant	Encourage more producers of the product, including generics 2	Encourage more producers of the product, including generics 3	Encourage more producers of the product, including generics 4	Encourage more producers of the product, including generics 5 Extremely relevant	Encourage more producers of the product, including generics
Emergency stock at capital level	Emergency stock at capital level 1-Not at all relevant	Emergency stock at capital level 2	Emergency stock at capital level 3	Emergency stock at capital level 4	Emergency stock at capital level 5 Extremely relevant	Emergency stock at capital level
Integrate the supply channel with the central ones	Integrate the supply channel with the central ones 1-Not at all relevant	Integrate the supply channel with the central ones 2	Integrate the supply channel with the central ones 3	Integrate the supply channel with the central ones 4	Integrate the supply channel with the central ones 5 Extremely relevant	Integrate the supply channel with the central ones

Other (please specify)

Question Title

* 1. Which of the anti-leishmanial commodities below that is available in your country

Question Title

* 2. Do you know if there is a leishmaniasis -or kala-azar- control programme in your country?

Question Title

* 3. As a neglected disease, who do you think procure the leishmaniasis drug and diagnostics? (multiple responses possible)

Question Title

* 4. Can you find leishmaniasis drugs outside public hospitals in your country?

Question Title

* 5. Can you purchase rapid test for leishmaniasis in the private pharmacies/lab in your country?

Question Title

* 6. Have you ever heard or experienced shortages of any of the anti leishmanial drug?

Question Title

* 7. If yes, which one?

Question Title

Question Title

* 9. Do you think the procurement of diagnostic and drugs for leishmaniasis should be integrated with the procurement for other essential medicines?

Question Title

* 10. On a scale from 1 (not at all relevant) to 5 (extremely relevant), please rate how important you think is that action. By importance, we mean how likely that action is to succeed to overcome the barriers.

Question Title

* 11. Which country are you currently live/work in?